Cue Biopharma Announces $50.0 Million Private Placement
Cue Biopharma secured approximately $50 million in gross proceeds through a private placement led by Cormorant Asset Management, selling 1.4 million shares at $33.21 per share and pre-funded warrants. Net proceeds are intended to fund clinical development and general corporate purposes as the company advances its portfolio of immunological disorder therapies.
Key figures
- Deal Value Usd
- 50000000
- Offering Price
- 33.21
- Shares Offered
- 1418071
- Warrant price
- 33.209
- Warrants offered
- 87500
- Warrant exercise price
- 0.001
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.